CWM
RDY icon

Congress Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Congress Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$426K Sell
28,358
-10,667
-27% -$152K ﹤0.01% 973
2025
Q1 		$515K Buy
+39,025
New +$538K 0.01% 809
2024
Q4 		– Sell
-34,685
Closed -$551K – 918
2024
Q3 		$551K Buy
+34,685
New +$558K 0.01% 624

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Congress Wealth Management's RDY Position: Q2 2025 in Review

Congress Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 27% in Q2 2025, selling an estimated $152K and leaving 28,358 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Congress Wealth Management first reported a position in RDY in Q3 2024 and has held it in 3 quarters since. The position peaked at $551K in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Congress Wealth Management held 28,358 shares of Dr. Reddy's Laboratories worth $426K as of Q2 2025.
  • Congress Wealth Management sold 10,667 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $152K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Congress Wealth Management's portfolio in Q2 2025, its #973 holding.
  • Congress Wealth Management first reported a position in Dr. Reddy's Laboratories in Q3 2024 and has held it in 3 quarters since.
  • Congress Wealth Management's Dr. Reddy's Laboratories position peaked at $551K in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.